Vincera Pharma Inc (VINC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6480 +0.0280 (+4.52%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6230 -0.0250 (-3.86%) 18:47 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,080 | -14,237 | -12,429 | -40,157 | -35,207 |
| Depreciation Amortization | 631 | 534 | 264 | 285 | 54 |
| Accounts payable and accrued liabilities | -534 | -961 | -183 | -1,568 | -1,003 |
| Other Working Capital | -1,632 | -1,181 | -1,306 | -4,191 | -375 |
| Other Operating Activity | 3,669 | 2,278 | 5,915 | 5,178 | 4,097 |
| Operating Cash Flow | $-19,946 | $-13,567 | $-7,739 | $-40,453 | $-32,434 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -11,463 | -8,337 | N/A | -11,821 | -11,821 |
| Sale Of Investment | 4,500 | N/A | N/A | 53,321 | 47,571 |
| Investing Cash Flow | $-6,963 | $-8,337 | $N/A | $41,500 | $35,750 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94 | 94 | 5 | 114 | 96 |
| Other Financing Activity | 16,913 | 16,913 | 0 | 0 | 0 |
| Financing Cash Flow | $17,007 | $17,007 | $5 | $114 | $96 |
| Exchange Rate Effect | 75 | 48 | 72 | -40 | 3 |
| Beginning Cash Position | 12,854 | 12,854 | 12,854 | 11,733 | 11,733 |
| End Cash Position | 3,027 | 8,005 | 5,192 | 12,854 | 15,148 |
| Net Cash Flow | $-9,827 | $-4,849 | $-7,662 | $1,121 | $3,415 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,946 | -13,567 | -7,739 | -40,453 | -32,434 |
| Free Cash Flow | -19,946 | -13,567 | -7,739 | -40,453 | -32,434 |